Virginia Commonwealth University Massey Cancer Center researchers have identified that a combination of novel anti-cancer compounds is able to kill chronic myelogenous leukemia cells previously resistant to conventional forms of therapy. Read more.
« Genetic Variant Linked to Dangerous Pregnancy Condition | Main | VCU School of Pharmacy awards 2008 Charles G. Thiel Award to Lars Borgström »